Table 2.
Analyte | MRM transition (m/z) | Declustering potential | Entrance potential | Collision energy | Exit potential |
---|---|---|---|---|---|
AB Sciex 3200 | |||||
bupropion | 240.2 > 184.1 | 31 | 3.5 | 15 | 14 |
bupropion-d9 | 249.2 > 185.0 | 36 | 5.5 | 17 | 14 |
hydroxybupropion | 256.2 > 238.2 | 36 | 3.5 | 17 | 20 |
hydroxybupropion-d6 | 262.2 > 244.2 | 36 | 5 | 17 | 20 |
erythrohydrobupropion | 242.0 > 168.1 | 31 | 4 | 21 | 14 |
erythrohydrobupropion-d9 | 251.1 > 169.0 | 41 | 8 | 25 | 3 |
threohydrobupropion | 242.0 > 168.1 | 31 | 4 | 21 | 14 |
threohydrobupropion-d9 | 251.1 > 169.0 | 41 | 8 | 25 | 3 |
AB Sciex 4000 QTRAP | |||||
bupropion | 240.0 > 184.0 | 56 | 10 | 19 | 28 |
bupropion-d9 | 249.3 > 185.1 | 61 | 10 | 19 | 12 |
hydroxybupropion | 256.1 > 238.1 | 46 | 10 | 17 | 6 |
hydroxybupropion-d6 | 262.3 > 131.1 | 61 | 10 | 43 | 22 |
erythrohydrobupropion | 242.1 > 168.1 | 66 | 10 | 23 | 26 |
erythrohydrobupropion-d9 | 251.2 > 169.2 | 106 | 10 | 27 | 28 |
threohydrobupropion | 242.1 > 168.1 | 66 | 10 | 23 | 26 |
threohydrobupropion-d9 | 251.2 > 169.2 | 106 | 10 | 27 | 28 |
AB Sciex 6500 | |||||
bupropion | 240.2 > 184.1 | 31 | 3.5 | 15 | 14 |
bupropion-d9 | 249.2 > 185.0 | 36 | 5.5 | 17 | 14 |
hydroxybupropion | 256.2 > 238.2 | 36 | 3.5 | 17 | 20 |
hydroxybupropion-d6 | 262.2 > 244.2 | 36 | 5.0 | 17 | 20 |
erythrohydrobupropion | 242.0 > 168.1 | 31 | 4.0 | 21 | 14 |
erythrohydrobupropion-d9 | 251.1 > 169.0 | 41 | 8.0 | 25 | 3 |
threohydrobupropion | 242.0 > 168.1 | 31 | 4.0 | 21 | 14 |
threohydrobupropion-d9 | 251.1 > 169.0 | 41 | 8.0 | 25 | 3 |